Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 588-592

  Zondag, Wendy ^a   Hiddinga, Birgitta I ^c   Crobach, Monique J T ^d   Labots, Geert ^e   Dolsma, Anneke ^b   Durian, Marc ^f   Faber, Laura M ^g   Hofstee, Herman M A ^h   Melissant, Christian F ⁱ   Ullmann, Eric F ^j   Vingerhoets, Lies M A ^k   De Vreede, Mariëlle J M ^d   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Dept of Pulmonology ^*  (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e Haga Hospital   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g RED CROSS HOSPITAL   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ N   (Netherlands)

^j RIJNSTATE HOSPITAL   (Netherlands)

^k RIJNLAND HOSPITAL   (Netherlands)

more..

Author keywords

Home treatment; Mortality; Outpatient treatment; Venous thromboembolism

Indexed keywords

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEMODYNAMICS; HIGH RISK PATIENT; HOME CARE; HOSPITAL ADMISSION; HUMAN; LOW RISK POPULATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE HEMATOMA; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PULMONARY EMBOLISM; PULMONARY MEDICINE; RECURRENCE; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84873580119     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00030412     Document Type: Article

References (12)

1. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th edn. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: E419S-e494S.
2. Janjua M, Badshah A, Matta F, et al. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost 2008; 100: 756-761.
3. Squizzato A, Galli M, Dentali F, et al. Outpatient treatment and early discharge of symptomatic pulmonary embolism: A systematic review. Eur Respir J 2009; 33: 1148-1155.
4. Erkens PM, Gandara E, Wells P, et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost 2010; 8: 2412-2417.
5. Kovacs MJ, Hawel JD, Rekman JF, et al. Ambulatory management of pulmonary embolism: A pragmatic evaluation. J Thromb Haemost 2010; 8: 2406-2411.
6. Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: The Hestia Study. J Thromb Haemost 2011; 9: 1500-1507.
7. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008; 133: 454S-545S.
8. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients. J Thromb Haemost 2005; 3: 692-694.
9. Aujesky D, Stone RA, Kim S, et al. Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: A statewide perspective. Arch Intern Med 2008; 168: 706-712.
10. van BA, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172-179.
11. Simonneau G, Sors H, Charbonnier B, et al. A comparison of lowmolecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997; 337: 663-669.
12. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: An international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41-48.